tiprankstipranks
Trending News
More News >
Lipocine (LPCN)
NASDAQ:LPCN
US Market

Lipocine (LPCN) Income Statement

Compare
889 Followers

Lipocine Income Statement

Last quarter (Q4 2024), Lipocine's total revenue was $3.49M, an increase of 1514.99% from the same quarter last year. In Q4, Lipocine's net income was $1.78M. See Lipocine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 11.20M$ -2.85M$ 500.00K$ 16.14M$ 0.00
Gross Profit
$ 11.20M$ -2.85M$ 500.00K$ 16.14M$ 0.00
Operating Expenses
$ 12.35M$ 15.08M$ 11.80M$ 16.64M$ 20.65M
Depreciation and Amortization
$ 41.11K$ 28.66K$ 9.45K$ 380.00$ 3.55K
EBITDA
$ -1.11M$ -16.32M$ -10.72M$ -430.53K$ -17.99M
Operating Income
$ -1.16M$ -17.93M$ -12.12M$ 3.15M$ -18.00M
Other Income/Expenses
$ 1.16M$ 1.58M$ 1.36M$ -3.78M$ -2.97M
Pretax Income
$ 9.03K$ -16.35M$ -10.76M$ -634.20K$ -20.96M
Net Income
$ 8.35K$ -16.35M$ -10.76M$ -634.40K$ -20.96M
Per Share Metrics
Basic EPS
$ 0.00$ -3.14$ -2.15$ -0.19$ -6.46
Diluted EPS
$ 0.00$ -3.14$ -2.05$ -0.12$ -6.40
Weighted Average Shares Outstanding
5.34M 5.27M 4.99M 3.30M 3.25M
Weighted Average Shares Outstanding (Diluted)
5.42M 5.27M 5.26M 5.15M 3.28M
Currency in USD

Lipocine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis